[
  {
    "ts": "2026-02-18T02:11:30+00:00",
    "headline": "Why Analysts See The TAT Technologies (NasdaqGM:TATT) Story Changing With New Targets And Assumptions",
    "summary": "TAT Technologies has seen its modeled fair value nudged from $54.33 to $56.17, with a slightly lower discount rate of 9.18% and a marginally higher revenue growth outlook at 16.24% now shaping the story. These updates reflect recent Street research that links a more constructive stance on the stock to assumptions for stronger revenue contributions and greater confidence in the company’s risk profile. Read on to see how you can keep track of these shifts and stay updated on the evolving...",
    "url": "https://finance.yahoo.com/news/why-analysts-see-tat-technologies-021130764.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8c255d81-6fb7-3b37-aa52-aaee64b17f82",
      "content": {
        "id": "8c255d81-6fb7-3b37-aa52-aaee64b17f82",
        "contentType": "STORY",
        "title": "Why Analysts See The TAT Technologies (NasdaqGM:TATT) Story Changing With New Targets And Assumptions",
        "description": "",
        "summary": "TAT Technologies has seen its modeled fair value nudged from $54.33 to $56.17, with a slightly lower discount rate of 9.18% and a marginally higher revenue growth outlook at 16.24% now shaping the story. These updates reflect recent Street research that links a more constructive stance on the stock to assumptions for stronger revenue contributions and greater confidence in the company’s risk profile. Read on to see how you can keep track of these shifts and stay updated on the evolving...",
        "pubDate": "2026-02-18T02:11:30Z",
        "displayTime": "2026-02-18T02:11:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4b379f9ed3f80f55476d72ed08ba4e52",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZPrh9KfMgYJyim8JH.gr3A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4b379f9ed3f80f55476d72ed08ba4e52.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BfAnMgVHjexb6TNUyQdj5A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4b379f9ed3f80f55476d72ed08ba4e52.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-tat-technologies-021130764.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-analysts-see-tat-technologies-021130764.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TATT"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T06:11:29+00:00",
    "headline": "Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth",
    "summary": "Cytokinetics, Incorporated (NASDAQ:CYTK) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the fifteen best healthcare stocks on our list. TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 […]",
    "url": "https://finance.yahoo.com/news/truist-notes-operational-investments-cytokinetics-061129300.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "feb5de3a-76bb-34ab-9fd0-61f0ab5e0d54",
      "content": {
        "id": "feb5de3a-76bb-34ab-9fd0-61f0ab5e0d54",
        "contentType": "STORY",
        "title": "Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth",
        "description": "",
        "summary": "Cytokinetics, Incorporated (NASDAQ:CYTK) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the fifteen best healthcare stocks on our list. TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 […]",
        "pubDate": "2026-02-18T06:11:29Z",
        "displayTime": "2026-02-18T06:11:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5348e66e2702f72d99a644e7ea290dc2",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Us6m8DX11fF7GddF7U40yg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/5348e66e2702f72d99a644e7ea290dc2.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9n01DhZc8ExEnZSW0kUQrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5348e66e2702f72d99a644e7ea290dc2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-notes-operational-investments-cytokinetics-061129300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-notes-operational-investments-cytokinetics-061129300.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TFC"
            },
            {
              "symbol": "CYTK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T06:06:23+00:00",
    "headline": "Truist Lowers PayPal (PYPL) Estimates Due to Slower Volume, Take Rate Compression",
    "summary": "PayPal Holdings Inc. (NASDAQ:PYPL) is one of the best stocks under $50 to invest in. On February 10, Truist lowered the firm’s price target on PayPal to $39 from $58 and kept a Sell rating as part of the firm’s broader research note. The note updated models for payment companies following Q4 2025 earnings. Truist […]",
    "url": "https://finance.yahoo.com/news/truist-lowers-paypal-pypl-estimates-060623299.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ce4ab98c-5849-3491-b349-a639b566a86c",
      "content": {
        "id": "ce4ab98c-5849-3491-b349-a639b566a86c",
        "contentType": "STORY",
        "title": "Truist Lowers PayPal (PYPL) Estimates Due to Slower Volume, Take Rate Compression",
        "description": "",
        "summary": "PayPal Holdings Inc. (NASDAQ:PYPL) is one of the best stocks under $50 to invest in. On February 10, Truist lowered the firm’s price target on PayPal to $39 from $58 and kept a Sell rating as part of the firm’s broader research note. The note updated models for payment companies following Q4 2025 earnings. Truist […]",
        "pubDate": "2026-02-18T06:06:23Z",
        "displayTime": "2026-02-18T06:06:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/94ed6617e434fd6d403db5475ccca47b",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Truist Lowers PayPal (PYPL) Estimates Due to Slower Volume, Take Rate Compression",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wY0nNFm0d72nWnjPPDEZ3w--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/94ed6617e434fd6d403db5475ccca47b.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.PCJrwYg5gF9.UcvD9JRkw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/94ed6617e434fd6d403db5475ccca47b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-lowers-paypal-pypl-estimates-060623299.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-lowers-paypal-pypl-estimates-060623299.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TFC"
            },
            {
              "symbol": "PYPL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]